Dupont Capital Management Corp Relay Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	BUY	$20.26 - $32.36 $44,369 - $70,868	2,190 Added 42.07%	7,396 $221,000
Q4 2021 Jan 31, 2022	SELL	$26.0 - $37.03 $53,976 - $76,874	-2,076 Reduced 28.51%	5,206 $160,000
Q3 2021 Nov 03, 2021	BUY	$29.75 - $37.99 $216,639 - $276,643	7,282 New	7,282 $230,000

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $577M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.